Gelonghui October 30th | Hubei Guangji Pharmaceutical (000952.SZ) released the third quarter report for 2024, achieving revenue of 0.462 billion yuan in the first three quarters, a decrease of 11.54% year-on-year; net income attributable to shareholders of the listed company -0.159 billion yuan; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses -0.172 billion yuan; basic earnings per share -0.4498 yuan.
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
- Headlines
- hubei guangji pharmaceutical (000952.SZ): a net loss of 0.159 billion yuan in the first three quarters.
广济药业(000952.SZ):前三季度净亏损1.59亿元
hubei guangji pharmaceutical (000952.SZ): a net loss of 0.159 billion yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
22:49
Country Garden: Due to failure to disclose the annual report for 2023 on time, the Shanghai Stock Exchange has decided to take self-disciplinary supervisory measures against the company.
COUNTRY GARDEN0.00%
22:47
Peskov: Unfriendly surroundings force Russia and Belarus to sign a security treaty.
22:47
Several high-performing stocks in the U.S. market saw their gains expand in early trading, with Rubrik rising over 28%, docusign up over 20%, Lululemon increasing nearly 17%, and ulta beauty climbing nearly 14%.
RBRK+27.74%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.